.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Federal Trade Commission
Argus Health
Johnson and Johnson
Cerilliant
Dow
US Army
Moodys
Cantor Fitzgerald

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050750

« Back to Dashboard

NDA 050750 describes ZOSYN IN PLASTIC CONTAINER, which is a drug marketed by Wyeth Pharms Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the ZOSYN IN PLASTIC CONTAINER profile page.

The generic ingredient in ZOSYN IN PLASTIC CONTAINER is piperacillin sodium; tazobactam sodium. There are fourteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.

Summary for 050750

Tradename:1
Applicant:1
Ingredient:1
Patents:4
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050750

Ingredient-typePenicillins
Mechanism of Actionbeta Lactamase Inhibitors

Suppliers and Packaging for NDA: 050750

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0206-2409 0206-2409-02 24 BAG in 1 BOX (0206-2409-02) > 50 mL in 1 BAG (0206-2409-01)
ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0206-2411 0206-2411-02 24 BAG in 1 BOX (0206-2411-02) > 50 mL in 1 BAG (0206-2411-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 40MG BASE/ML;EQ 5MG BASE/ML
Approval Date:Feb 24, 1998TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 22, 2019Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Apr 14, 2023Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF TREATING BACTERIAL INFECTIONS
Patent:► SubscribePatent Expiration:Apr 14, 2023Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
Fuji
Covington
Cerilliant
Express Scripts
Queensland Health
Federal Trade Commission
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot